ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Panel Objects To Act Change Requiring NCI Carcinogen Report

May 12, 1978

Legislation Would Create Medicare Service For Comprehensive Cancer Care planning.

May 26, 2006

In Brief: Urologist Appointed To NCAB; Stovall Named To US Pharmacopeia Oncology Advisory Panel

September 8, 1995

NCI FY 1986 Bypass Budget Asks 41.445 Billion with Major Increase Tied To Goal for Year 2000

May 18, 1984

Hormone Therapy At Menopause Linked to More Breast Cancer Risk

February 25, 2011

In Brief: Broder to Discuss Centers Plan Between Meeting; Symposium Depicted To William Scott

May 11, 1990